Doctors have found that antidepressant (PDE-5 inhibitors) medicines have shown positive results in controlling the Dhat syndromes psychological causes." Epidemiology
Dhat syndrome has been reported throughout South Asia in several communities." History
The term Dhat gets its origin from the Sanskrit word Dhatu (धातु), which, according to the Sushruta Samhita, means "elixir that constitutes the body". Indian doctor Narendra Wig coined the term Dhat syndrome in 1960 and described it as being characterized by vague psychosomatic symptoms of fatigue, weakness, anxiety, loss of appetite, guilt, and sexual dysfunction, attributed by the patient to loss of semen in nocturnal emission, through urine or masturbation. Literature describing semen as a vital constituent of the human body dates back to 1500 BC. The disorders of Dhatus have been elucidated in the Charaka Samhita, which describes a disorder called Shukrameha (शुक्रमेह) in which there is a passage of semen in the urine. In China, various names such as (Shen Kuei), Sri Lanka (Prameha) and other parts of South East Asia (Jiryan) symptoms and conditions are similar to dhatus. The International Classification of diseases ICD-10 classifies Dhat syndrome as both a neurotic disorder (code F48.8) and a culture-specific disorder (Annexe 2) caused by "undue concern about the debilitating effects of the passage of semen". Society and culture
Some doctors believe Dhat syndrome to be either a culture-bound presentation of clinical depression, as a somatized set of symptoms, or a result of Western doctors misinterpretation of patients descriptions of their condition.Dhat syndrome is very common in Nepali culture as well.
There are different types of delivery systems of progestogens that can be used in addition to an estrogen patch, including pills, injections, and patches, among others.Research has suggested that estrogen plus progestogen therapy may increase the risk of heart attacks, stroke, breast cancer, blot clots, and dementia in postmenopausal women. Taking the lowest effective dose of both estrogen and a progestogen may reduce risks. Administration
Depending on the brand, patches are applied to the skin once or twice weekly. Patches should be placed on clean skin where hair and moisture is not present. Preferred areas of application include lower abdomen, hip, and buttocks. Patches should never be applied to the breasts. To reduce the risk of the patch detaching from the skin and skin irritation, skin care products, sun exposure, damaged skin, and tight-fitting clothing should be avoided where the patch is placed. Side effects
Headache, breast pain or tenderness, nausea, vomiting, hair loss, vaginal discharge or irritation, and mood changes are some of the common side effects that may occur while using an estrogen patch. More serious side effects may include fever, loss of appetite, joint pain, difficulty breathing or swallowing, and yellowing of the skin or eyes.Seeing a health professional regularly, taking progestin, having pelvic and breast exams, lowering blood pressure, and lowering cholesterol may reduce the likelihood of developing severe side effects while using an estrogen patch.